Protease-armed, Pathogenic Extracellular Vesicles Link Smoking and COPD

Matthew C Madison,Camilla Margaroli,Kristopher R Genschmer,Derek W Russell,James M Wells,Ezgi Sari,Yixel M Soto-Vazquez,Yuan-Yuan Guo,Kyle T Mincham,Robert J Snelgrove,Amit Gaggar,James E Blalock,Kristopher R. Genschmer,Yixel M. Soto-Vazquez,Robert J. Snelgrove
DOI: https://doi.org/10.1164/rccm.202303-0471oc
IF: 24.7
2023-09-15
American Journal of Respiratory and Critical Care Medicine
Abstract:RATIONALE: <AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">Mounting evidence demonstrates a role for extracellular vesicles (EVs) in driving lung disorders, such as COPD. While cigarette smoke (CS) is the primary risk factor for COPD, a link between CS and the EVs that could lead to COPD is unknown.</AbstractText>OBJECTIVE: <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To ascertain whether exposure to CS elicits a proteolytic EV signature capable of driving disease pathogenesis.</AbstractText>METHODS: <AbstractText Label="METHODS" NlmCategory="METHODS">Protease expression and enzymatic activity was measured in EVs harvested from the BAL fluid of smoke-exposed mice and otherwise healthy human smokers. Pathogenicity of EVs was examined using pathological tissue scoring following EV transfer into naïve recipient mice.</AbstractText>MEASUREMENTS & MAIN RESULTS: <AbstractText Label="MEASUREMENTS & MAIN RESULTS" NlmCategory="RESULTS">Our analyses reveal a unique EV profile defined by neutrophil and macrophage-derived EVs. These EVs are characterized by abundant surface expression of neutrophil elastase (NE) and matrix metalloproteinase (MMP-12), respectively. CS-induced mouse or human-derived airway EVs had a robust capacity to elicit rapid lung damage in naïve recipient mice, with an additive effect of NE and MMP-12-expressing EVs.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These studies demonstrate the capacity of CS to drive the generation of unique EV populations containing NE and MMP-12. The coordinated action of these EVs is completely sufficient to drive emphysematous disease, and their presence could operate as a prognostic indicator for COPD development. Furthermore, given the robust capacity of these EVs to elicit emphysema in naïve mice, they provide a novel model to facilitate pre-clinical COPD research. Indeed, the development of this model has led to the discovery of a previously unrecognized CS-induced protective mechanism against EV-mediated damage.</AbstractText>
respiratory system,critical care medicine
What problem does this paper attempt to address?